AgomAb Therapeutics NV · NASDAQ:AGMB
Epstein David R bought 15,000 AgomAb Therapeutics NV shares (Form 4)
Traded Nov 5, 2026 · Filed Nov 6, 2026
On Nov 5, 2026, Epstein David R (Director) bought 15,000 AgomAb Therapeutics NV shares at an average US$6.90 for US$104K, leaving 40,000 shares. Filed Nov 6, 2026 (Form 4).
- Bought
- 15,000 shares
- Price
- US$6.90 average (US$6.81 to US$6.98)
- Value
- US$104K
- Holding after
- 40,000 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Common shares | Buy | 5,000 | US$6.81 | 30,000 | Direct |
| Nov 5, 2026 | Common shares | Buy | 5,000 | US$6.91 | 35,000 | Direct |
| Nov 5, 2026 | Common shares | Buy | 5,000 | US$6.98 | 40,000 | Direct |
Source
Download original · View original at SEC